XMD-8-92 | Interleukin Related interleukin-related.com

Product Name :
XMD-8-92

Search keywords :
XMD8-92

drugId :
null

Target Vo:
Extracellular-signal-regulated kinase 5

Target Vo Short Name :
ERK5

Moa_Name:
Extracellular-signal-regulated kinase 5 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Dana-Farber Cancer Institute

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Lorvotuzumab Purity
Anti-6X His-tag (C-terminal) Mouse mAb Cancer
Ku70 Antibody (YA319): Ku70 Antibody (YA319) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts